Health Care • Industrial Specialties
$1.36 ▲ +0.13
(+10.57%)
MKT CAP: $9.6M • VOL: 61.9K
52W L $1 52W H $16
ROARABLE / RQD
D • 44/100
PIOTROSKI
1 / 9
RGNT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$7.0M | $932.0K | -$1.9M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$13.6M | $4.8M | -$4.1M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.4M | -$641.0K | -$1.2M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | -$1.4M | -$641.0K | -$1.2M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $7.4M | — | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $4.7M | -$41.1M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR RGNT.